Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Gold Herb, officially Zhejiang New Gold Herb Biotechnology Co., Ltd., is a specialized biotechnology firm focused on the research, cultivation, and production of Dendrobium officinale, a precious herb in Traditional Chinese Medicine. Based in Zhejiang, China, the company operates extensive standardized cultivation bases that utilize modern agricultural technology to ensure the quality and purity of its raw materials. Its product portfolio includes high-end health supplements such as Dendrobium powders, extracts, and functional food products marketed under the Xinjincao brand. New Gold Herb integrates traditional herbal wisdom with contemporary biotechnology to develop products aimed at immune support, glucose regulation, and overall wellness. The company is a significant player in the industrialization of Dendrobium in the Wenzhou region and is recognized as a high-tech enterprise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Gold Herb.